Early research (Phase 1)Study completedNCT00480558What this trial is testingMVA85A, in Asymptomatic Volunteers Infected With TB, HIV or BothWho this might be right forHIV InfectionsTB University of Oxford 48
Not applicableUnknownNCT03941210What this trial is testingMicro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected PatientsWho this might be right forHIV InfectionTuberculosis Infection ANRS, Emerging Infectious Diseases 134
Not applicableActive Not RecruitingNCT05671159What this trial is testingCOMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients Admitted to Intensive Care UnitWho this might be right forViral InfectionSepsis University Hospital, Limoges 38
Large-scale testing (Phase 3)Study completedNCT02759354What this trial is testingLong-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)Who this might be right forHepatitis BPertussis MCM Vaccines B.V. 754
Not applicableStudy completedNCT00002032What this trial is testingRifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled TrialWho this might be right forMycobacterium Avium-intracellulare InfectionHIV Infections Pharmacia 750
Testing effectiveness (Phase 2)Looking for participantsNCT05123755What this trial is testingPhase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.Who this might be right forAcute Respiratory Distress SyndromeViral or Bacterial InfectionsPneumonia+3 more Vasomune Therapeutics, Inc. 120
Large-scale testing (Phase 3)Study completedNCT01983540What this trial is testingAntibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationWho this might be right forDiphtheriaTetanusWhooping Cough+3 more Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Study completedNCT00145249What this trial is testingAmphotericin Alone or in Combination With Fluconazole for AIDS-Associated MeningitisWho this might be right forCryptococcal Meningitis National Institute of Allergy and Infectious Diseases (NIAID) 143
Not applicableLooking for participantsNCT06657781What this trial is testingStudy and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral SepsisWho this might be right forBacterial Sepsis Centre Hospitalier Universitaire de la Guadeloupe 171
Not applicableStudy completedNCT01917461What this trial is testingObservational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral InfectionsWho this might be right forLRTIUTIGastroenteritis+2 more MeMed Diagnostics Ltd. 1,001
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Not applicableStudy completedNCT00015704What this trial is testingEffect of Interleukin-2 on HIV Treatment InterruptionWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableUnknownNCT05292508What this trial is testingComparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood TestWho this might be right forAcute Febrile IllnessUse of Antimicrobial AgentsC-reactive Protein Level Patan Academy of Health Sciences 924
Large-scale testing (Phase 3)Study completedNCT00654901What this trial is testingStudy of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™Who this might be right forDiphtheriaTetanusPertussis+3 more Sanofi Pasteur, a Sanofi Company 881
Testing effectiveness (Phase 2)Study completedNCT03819114What this trial is testingPharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis TherapyWho this might be right forHIV InfectionsTuberculosis Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Testing effectiveness (Phase 2)Ended earlyNCT01601626What this trial is testingRifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVWho this might be right forHIV InfectionTuberculosis Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 71
Large-scale testing (Phase 3)Study completedNCT00002159What this trial is testingA Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or HistoplasmosisWho this might be right forHIV InfectionsHistoplasmosisBlastomycosis Janssen, LP 60
Not applicableStudy completedNCT01789268What this trial is testingImpact of Respiratory Pathogens in InfantsWho this might be right forRespiratory Tract Infection University of Rochester 267
Not applicableStudy completedNCT00002080What this trial is testingRifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND StudyWho this might be right forMycobacterium Avium-intracellulare InfectionHIV Infections Pharmacia
Large-scale testing (Phase 3)Study completedNCT00001028What this trial is testingPentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or SulfonamidesWho this might be right forPneumonia, Pneumocystis CariniiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 400